Related Experiment Video
Updated: Aug 24, 2025

Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation
Published on: August 14, 2017
Molecular interplay of ADAMTS13-MDTCS and von willebrand Factor-A2: deepened insights from extensive atomistic
Norman Geist1, Felix Nagel1, Mihaela Delcea1
1University of Greifswald, Biophysical Chemistry, Institute of Biochemistry, Greifswald, Germany.
Abstract:
Thrombotic thrombocytopenic purpura (TTP) is a rare and life-threatening disease. One hallmark is severe ADAMTS13 deficiency, causing ultra-large von Willebrand factor (VWF) multimers to accumulate, leading to microthrombi and lastly to microangiopathic hemolytic anemia and severe thrombocytopenia. Despite great success in recent decades, the molecular picture of the interaction between VWF and ADAMTS13 remains vague. Here, we utilized modern replica-exchange molecular dynamics simulations with the TIGER2h method to sample a vast configurational space of the isolated ADAMTS13-MDTCS domains and the exposure to its substrate and activating cofactor - the unraveled VWF-A2 domain. The sampling of binding sites and conformations was guided and filtered in agreement with available experimental evidence. We provide comprehensive information on exosites for each domain and direct pairs of interacting amino acids, for the first time. The major binding cluster for the active site of the MP domain contrasts the previous mapping of VWF-A2 residues and reciprocal binding pockets. Two major binding modes are revealed and provide access to conformational changes of an extended gatekeeper tetrad upon overcoming local latency during substrate binding and to a dedicated recruitment mechanism. Our work adds the first molecular interaction model that places previous experimental results in perspective to better understand disease-related mutations towards improved therapies. Numerous empirical targets are proposed to verify the given binding modes, to refine the overall picture of MP binding pockets, the role of Dis binding in MP activation and the passage of the Cys-rich domain through VWF-A2, thus deepening the understanding of a highly dynamic interplay.Communicated by Ramaswamy H. Sarma.
Insights
Thrombotic thrombocytopenic purpura (TTP) is a rare disease caused by ADAMTS13 deficiency. This study reveals the molecular interactions between ADAMTS13 and von Willebrand factor (VWF), providing a new model for understanding TTP.
Area of Science:
- Biochemistry
- Molecular Biology
- Computational Biology
Background:
- Thrombotic thrombocytopenic purpura (TTP) is a critical condition characterized by severe ADAMTS13 deficiency.
- This deficiency leads to the accumulation of ultra-large von Willebrand factor (VWF) multimers, causing microthrombi, microangiopathic hemolytic anemia, and thrombocytopenia.
- The precise molecular mechanisms governing the interaction between VWF and ADAMTS13 remain incompletely understood.
Purpose of the Study:
- To elucidate the molecular interactions between the ADAMTS13 enzyme and its substrate, the VWF-A2 domain.
- To develop a molecular interaction model for ADAMTS13-VWF binding.
- To provide a framework for understanding TTP pathogenesis and guiding therapeutic development.
Main Methods:
- Utilized replica-exchange molecular dynamics simulations with the TIGER2h method.
- Sampled extensive configurational space of ADAMTS13-MDTCS domains and the VWF-A2 domain.
- Filtered simulations based on available experimental data to identify relevant binding sites and conformations.
Main Results:
- Provided the first comprehensive map of exosites and interacting amino acid pairs between ADAMTS13 and VWF-A2.
- Identified a major binding cluster for the ADAMTS13 MP domain that differs from previous VWF-A2 residue mapping.
- Revealed two primary binding modes, detailing conformational changes and a recruitment mechanism during substrate binding.
Conclusions:
- Developed the first molecular interaction model of ADAMTS13-VWF binding, integrating experimental findings.
- The model offers insights into disease-related mutations and potential therapeutic strategies for TTP.
- Proposed empirical targets for further validation of binding modes and understanding the dynamic interplay in TTP.
More Related Videos
10:52Multiscale Sampling of a Heterogeneous Water/Metal Catalyst Interface using Density Functional Theory and Force-Field Molecular Dynamics
Published on: April 12, 2019
15:05Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
Published on: May 20, 2020